University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Prestwich, R"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 17.

Article

Adair, RA, Roulstone, V, Scott, KJ, Morgan, R, Nuovo, GJ, Fuller, M, Beirne, D, West, EJ, Jennings, VA, Rose, A, Kyula, J, Fraser, S, Dave, R, Anthoney, DA, Merrick, A, Prestwich, R, Aldouri, A, Donnelly, O, Pandha, H, Coffey, M, Selby, P, Vile, R, Toogood, G, Harrington, K and Melcher, AA (2012) Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients. Sci Transl Med, 4 (138).

Donnelly, OG, Errington-Mais, F, Prestwich, R, Harrington, K, Pandha, H, Vile, R and Melcher, AA (2011) Recent Clinical Experience With Oncolytic Viruses. Curr Pharm Biotechnol.

Steele, L, Errington, F, Prestwich, R, Ilett, E, Harrington, K, Pandha, H, Coffey, M, Selby, P, Vile, R and Melcher, A (2011) Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-kappa B mediated and supports innate and adaptive anti-tumour immune priming MOLECULAR CANCER, 10, ARTN 20.

Heinemann, L, Simpson, GR, Boxall, A, Kottke, T, Relph, KL, Vile, R, Melcher, A, Prestwich, R, Harrington, KJ, Morgan, R and Pandha, HS (2011) Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. BMC Cancer, 11.

Heinemann, L, Simpson, GR, Annels, NE, Vile, R, Melcher, A, Prestwich, R, Harrington, KJ and Pandha, HS (2010) The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis MOLECULAR THERAPY, 18 (12). pp. 2085-2093.

Harrington, KJ, Karapanagiotou, EM, Roulstone, V, Twigger, KR, White, CL, Vidal, L, Beirne, D, Prestwich, R, Newbold, K, Ahmed, M, Thway, K, Nutting, CM, Coffey, M, Harris, D, Vile, RG, Pandha, HS, DeBono, JS and Melcher, AA (2010) Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers CLINICAL CANCER RESEARCH, 16 (11). pp. 3067-3077.

Prestwich, RJ, Errington, F, Diaz, RM, Pandha, HS, Harrington, KJ, Melcher, AA and Vile, RG (2009) The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon HUMAN GENE THERAPY, 20 (10). pp. 1119-1132.

Prestwich, RJ, Errington, F, Steele, LP, Ilett, EJ, Morgan, RSM, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG and Melcher, AA (2009) Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus JOURNAL OF IMMUNOLOGY, 183 (7). pp. 4312-4321.

Pandha, Hardev, Heinemann, Lucy, Simpson, Guy, Melcher, A, Prestwich, R, Errington, F, Coffey, M, Harrington, KJ and Morgan, Richard (2009) Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma Clinical Cancer Research, 15 (19). pp. 6158-6166.

Prestwich, RJ, Ilett, EJ, Errington, F, Diaz, RM, Steele, LP, Kottke, T, Thompson, J, Galivo, F, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG and Melcher, AA (2009) Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication CLINICAL CANCER RESEARCH, 15 (13). pp. 4374-4381.

Ilett, EJ, Prestwich, RJ, Kottke, T, Errington, F, Thompson, JM, Harrington, KJ, Pandha, HS, Coffey, M, Selby, PJ, Vile, RG and Melcher, AA (2009) Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity GENE THERAPY, 16 (5). pp. 689-699.

Prestwich, RJ, Scott, KJ, Brown, J, Harnden, P, Whelan, P, Cartledge, J, O'Donnell, D, Pandha, HS, Selby, PJ, Banks, RE, Merrick, AE and Melcher, AA (2009) The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma BJU INTERNATIONAL, 103 (6). pp. 740-746.

Prestwich, RJ, Errington, F, Ilett, EJ, Morgan, RSM, Scott, KJ, Kottke, T, Thompson, J, Morrison, EE, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG and Melcher, AA (2008) Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity CLINICAL CANCER RESEARCH, 14 (22). pp. 7358-7366.

Prestwich, RJ, Harrington, KJ, Pandha, HS, Vile, RG, Melcher, AA and Errington, F (2008) Oncolytic viruses: a novel form of immunotherapy EXPERT REVIEW OF ANTICANCER THERAPY, 8 (10). pp. 1581-1588.

Errington, F, White, CL, Twigger, KR, Rose, A, Scott, K, Steele, L, Ilett, LJ, Prestwich, R, Pandha, HS, Coffey, M, Selby, P, Vile, R, Harrington, KJ and Melcher, AA (2008) Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma GENE THERAPY, 15 (18). pp. 1257-1270.

Errington, F, Steele, L, Prestwich, R, Harrington, KJ, Pandha, HS, Vidal, L, de Bono, J, Selby, P, Coffey, M, Vile, R and Melcher, A (2008) Reovirus activates human dendritic cells to promote innate antitumor immunity JOURNAL OF IMMUNOLOGY, 180 (9). pp. 6018-6026.

Prestwich, RJ, Errington, F, Harrington, KJ, Pandha, HS, Selby, P and Melcher, A (2008) Oncolytic viruses: do they have a role in anti-cancer therapy? Clin Med Oncol, 2. pp. 83-96.

This list was generated on Wed Feb 26 05:03:46 2020 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800